M

    Moderna Inc (MRNA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $140.34
    +2.35 (+1.70%)

    Market Cap: $56.03B

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    68%(21/31)
    Avg Surprise
    -11.29%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-1.35
    Range$-3.32 - $-0.80
    14 analysts
    EPS Revisions
    7
    0
    7d
    7
    7
    30d
    EPS Estimate Drift
    90d ago$-1.13+16.4%
    60d ago$-1.13+16.4%
    30d ago$-1.22+9.3%
    7d ago$-1.35+0.0%
    Current$-1.35
    Revenue Consensus
    $873M
    Range$827M - $944M
    13 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-1.27
    Range$-3.26 - $-0.71
    19 analysts
    Revenue Consensus
    $893M
    Range$750M - $1.1B
    21 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-1.27---
    Sep 26EST
    		-$-1.35---
    Jun 26
    Reported Jul 31
    		$-1.97$-1.97+0.00%Beat+7.5%
    Mar 26
    Reported May 1
    		$-3.40$-2.11-61.14%Miss-34.9%
    Dec 25
    Reported Feb 13
    		$-2.11$-2.64+20.08%Beat+27.5%
    Sep 25
    Reported Nov 6
    		$-0.51N/A+76.39%Beat-1800.0%
    Jun 25
    Reported Aug 1
    		$-2.13$-3.00+29.00%Beat+36.0%
    Mar 25
    Reported May 1
    		$-2.52$-3.11+18.97%Beat+17.9%
    Dec 24
    Reported Feb 14
    		$-2.91$-2.76-5.44%Miss-629.1%
    Sep 24
    Reported Nov 7
    		$0.03N/A+101.58%Beat+100.3%
    Jun 24
    Reported Aug 1
    		$-3.33$-3.35+0.60%Beat+8.0%
    Mar 24
    Reported May 2
    		$-3.07$-3.57+14.01%Beat-1715.8%
    Dec 23
    Reported Feb 22
    		$0.55$-0.97+156.70%Beat-84.8%
    Sep 23
    Reported Nov 2
    		$-9.53$-2.05-364.88%Miss-476.7%
    Jun 23
    Reported Aug 3
    		$-3.62$-4.12+12.14%Beat-169.1%
    Mar 23
    Reported May 4
    		$0.19N/A+110.73%Beat-97.8%
    Dec 22
    Reported Feb 23
    		$3.61$4.60-21.52%Miss-68.0%
    Sep 22
    Reported Nov 3
    		$2.53$3.11-18.65%Miss-67.1%
    Jun 22
    Reported Aug 3
    		$5.24$4.49+16.70%Beat-18.9%
    Mar 22
    Reported May 4
    		$8.58$5.62+52.67%Beat+202.1%
    Dec 21
    Reported Feb 24
    		$11.29$9.90+14.04%Beat+1736.2%
    Sep 21
    Reported Nov 4
    		$7.70$9.42-18.26%Miss+1405.1%
    Jun 21
    Reported Aug 5
    		$6.46$5.86+10.24%Beat+2183.9%
    Mar 21
    Reported May 6
    		$2.84$2.47+14.98%Beat+911.4%
    Dec 20
    Reported Feb 25
    		$-0.69$-0.35-97.14%Miss-86.5%
    Sep 20
    Reported Oct 29
    		$-0.59$-0.37-59.46%Miss-59.5%
    Jun 20
    Reported Aug 5
    		$-0.31$-0.36+13.89%Beat+24.4%
    Mar 20
    Reported May 7
    		$-0.35$-0.36+2.78%Beat+12.5%
    Dec 19
    Reported Feb 26
    		$-0.37$-0.42+11.90%Beat+79.2%
    Sep 19
    Reported Nov 6
    		$-0.37$-0.44+15.91%Beat+28.8%
    Jun 19
    Reported Aug 7
    		$-0.41$-0.45+8.89%Beat-41.4%
    Mar 19
    Reported May 9
    		$-0.40$-0.36-11.11%Miss-
    Dec 18
    Reported Mar 6
    		$-1.78$-0.36-394.44%Miss-
    Sep 18
    Reported Dec 7
    		$-0.52$0.00N/AMiss-
    Jun 18
    Reported Jun 30
    		$-0.29N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-17.56EV/EBITDA4.64x
    Price/FCF-44.90xFCF Yield-2.23%
    Profitability
    Profit Margin-141.40%Operating Margin-558.00%
    ROE-39.00%ROIC-45.82%
    Financial Health
    Debt/Equity0.09xInterest CoverageN/A
    Current Ratio2.29xQuick Ratio2.18x
    Trading Statistics
    Beta0.90Avg Volume29.31M
    52-Week High$176.6652-Week Low$22.28

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$138.43
    SMA 20$99.30
    SMA 50$78.32
    SMA 200$52.33
    EMA 10$130.87
    EMA 20$111.12
    EMA 50$85.78
    EMA 200$57.73

    MACD

    Line: 23.03Signal: 18.60Hist: 4.43

    ADX

    ADX: 46.4+DI: 43.8-DI: 8.4

    Aroon & PSAR

    Aroon Up68.0
    Aroon Down20.0
    PSAR$175.79

    Bollinger Bands

    Upper Band$189.17
    Lower Band$9.44
    %B Position18100%(Upper)
    Band Width0.73

    RSI (14-Day)

    Neutral
    64.1

    Momentum Oscillators

    Stoch %K69.2
    Stoch %D73.2
    Williams %R-30.9
    ROC (10d)117.7%
    Momentum75.88
    CCI (20d)65.8
    MFI (14d)64.7

    Volatility Measures

    ATR (14d)$14.34(10.2%)
    StdDev (20d)44.93
    Hist Vol640.1%(High)

    Volume Flow

    VWAP$139.47
    OBV391.3M
    AD Line172.2M
    CMF (20d)0.279

    Volume Metrics

    Avg Vol (20d)30.5M
    Vol Ratio0.6x
    VWMA (20d)$144.06

    Pivot Points

    R3$145.55
    R2$142.18
    R1$140.08
    Pivot Point$136.71
    S1$134.61
    S2$131.24
    S3$129.14

    Advanced Oscillators

    TSI35.17
    Ultimate Osc59.9
    KST1122.09

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$145.00M$389.00M$678.00M$1.02B$142.00M$108.00M$966.00M$1.86B$241.00M$167.00M$2.81B$1.83B
    Cost of Revenue$93.00M$955.00M$452.00M$207.00M$119.00M$90.00M$739.00M$514.00M$115.00M$96.00M$929.00M$2.24B
    Gross Profit$52.00M$-566,000,000$226.00M$809.00M$23.00M$18.00M$227.00M$1.35B$126.00M$71.00M$1.88B$-410,000,000
    Operating Expenses$867.00M$822.00M$1.08B$1.07B$930.00M$1.07B$1.47B$1.42B$1.49B$1.34B$1.88B$1.60B
    R&D$651.00M$649.00M$775.00M$801.00M$700.00M$856.00M$1.12B$1.14B$1.22B$1.06B$1.41B$1.16B
    SG&A$216.00M$173.00M$308.00M$268.00M$230.00M$212.00M$351.00M$281.00M$268.00M$274.00M$470.00M$442.00M
    Operating Income$-815,000,000$-1,388,000,000$-857,000,000$-260,000,000$-907,000,000$-1,050,000,000$-1,246,000,000$-70,000,000$-1,363,000,000$-1,266,000,000$6.00M$-2,012,000,000
    Interest Income$67.00M$72.00M$70.00M$73.00M$81.00M$90.00M$91.00M$103.00M$111.00M$120.00M$103.00M$105.00M
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-767,000,000$-1,334,000,000$-799,000,000$-187,000,000$-818,000,000$-964,000,000$-1,184,000,000$21.00M$-1,279,000,000$-1,165,000,000$70.00M$-1,958,000,000
    Income Tax Expense$15.00M$9.00M$27.00M$13.00M$7.00M$7.00M$-64,000,000$8.00M$0$10.00M$-147,000,000$1.67B
    Net Income$-782,000,000$-1,343,000,000$-826,000,000$-200,000,000$-825,000,000$-971,000,000$-1,120,000,000$13.00M$-1,279,000,000$-1,175,000,000$217.00M$-3,630,000,000
    EBITDA$-781,000,000$-1,358,000,000$-815,000,000$-225,000,000$-860,000,000$-1,034,000,000$-1,234,000,000$-51,000,000$-1,377,000,000$-1,276,000,000$149.00M$-1,826,000,000
    EBIT$-834,000,000$-1,406,000,000$-869,000,000$-260,000,000$-899,000,000$-1,054,000,000$-1,275,000,000$-82,000,000$-1,390,000,000$-1,285,000,000$-33,000,000$-2,063,000,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about MRNA

    News

    Moderna Raises $3 Billion via Convertible Notes Offering

    Moderna successfully raised $3.0 billion through a private offering of 0.00% Convertible Senior Notes due 2032, providing non-dilutive capital and financial flexibility. The notes, with an initial conversion price of approximately $210.58 per share, allow for conversion into cash, stock, or a combination. The company utilized a portion of the proceeds for capped call transactions to mitigate shareholder dilution and plans to use the remaining funds for general corporate purposes, including investments in oncology growth and debt repayment.

    TipRanks•9/1/26•
    Somewhat-Bullish

    Mirion Technologies Launches $250 Million Five-Year Stock Buyback Program

    Mirion Technologies, Inc. announced a new five-year stock repurchase program of up to $250 million, effective August 31, 2026, and lasting until August 31, 2031. This initiative follows the near completion of its previous $100 million buyback plan, with approximately 2.6 million shares repurchased for $40 million in Q3 2026. The company reserves the right to suspend or terminate the program at any time without prior notice, and repurchase timing and prices are not assured.

    Kalkine Media•9/1/26•
    Neutral

    U.S. Markets Decreased Tuesday; Pershing Square Fell Furthest

    U.S. stock markets experienced a decline on Tuesday, with the NASDAQ Composite Index falling 1.03%. The Dow Jones Industrial Average decreased by 0.79%, and the S&P 500 Index dropped 0.71%. The article highlights Pershing Square as the biggest faller among the discussed stocks.

    Barron's•9/1/26•
    Bearish

    Darden Restaurants Director Daryl Kenningham Converts 150 Restricted Stock Units to Common Shares

    Daryl Kenningham, a director at Darden Restaurants Inc. (NYSE: DRI), converted 150 restricted stock units into common shares on August 30, 2026, as disclosed in a Statement of Changes in Beneficial Ownership. This conversion, part of his FY26 Director Compensation and quarterly retainer election, increased his direct ownership to 1,924 common shares. The transaction was at no cost, with the units immediately settling into common stock.

    Kalkine Media•9/1/26•
    Neutral

    Moderna to Present at Upcoming Conferences in September 2026

    Moderna, Inc. (Nasdaq: MRNA) announced its participation in two upcoming investor conferences in September 2026: the Morgan Stanley 24th Annual Global Healthcare Conference and the Bernstein Insights: Healthcare Leaders and Disruptors 3rd Annual Healthcare Forum. Live webcasts and replays of these presentations will be available on the Investors section of Moderna's website. The company will discuss its advancements in mRNA medicine across various disease areas.

    Investing News Network•9/1/26•
    Neutral

    Frequently Asked Questions About MRNA

    Does MRNA pay dividends?
    Moderna Inc (MRNA) does not currently pay a regular dividend.
    What is MRNA's market cap?
    Moderna Inc (MRNA) has a market capitalization of $56.03B with a current stock price of $140.34.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In